When the wrong stuff takes over stubborn fat, blood sugar spikes, out-of-control cravings your whole system feels it
Being a leader in microneedling TDDS, their unique micro needle technology, DEN (Droplet Extension Needle), allows them to transfer drugs through a soluble micro needle. Raphas has FDA cGMP manufacturing validation for microneedle skin patches and has completed Phase 1 clinical trials
Compared to earlier GLP-1 receptor agonists such as liraglutide (available as Victoza and Saxenda), dulaglutide (Trulicity), and exenatide (Byetta and Bydureon), Ozempic has shown greater efficacy in clinical studies
On the other hand, the actual GLP-1 microneedle patches with GLP-1 analogues like semaglutide are said to show results like reduced appetite and cravings, feelings of fullness and delayed gastric emptying 4
however, they are still not approved for use and available in the market
Patients beginning treatment with semaglutide can expect a gradual weight loss trajectory